Intensity Therapeutics Forms Scientific Advisory Board Comprised of World-Leading Oncologists and Scientists
October 22, 2015 07:35 ET
|
Intensity Therapeutics Inc
Westport, CT, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a privately-held biotechnology company developing proprietary immune cell activating anti-cancer drug products, announced...